NCT02360254View on ClinicalTrials.gov

Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Insulin degludec

Once daily injection of insulin degludec

Trial Locations (1)

35128

Division of Metabolic Diseases, University Hospital of Padova, Padua

All Listed Sponsors
collaborator

Azienda Ospedaliera di Padova

OTHER

lead

University of Padova

OTHER

NCT02360254 - Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes | Biotech Hunter | Biotech Hunter